L-NIL is used as a selective inhibitor of inducible nitric oxide synthase (iNOS), with applications in research related to inflammation, oxidative stress, and autophagy. It is particularly effective in preventing renal ischemia-reperfusion (IR)-induced inflammation, oxidative stress, and autophagy in mice. Additionally, L-NIL modulates immune responses by significantly reducing TLR4 and IL-1β protein levels and clusterin transcript, while increasing NFAT5 mRNA levels and decreasing AR protein expression in septic mice.